◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
MRK
MRK
(MRK)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
GlobeNewswire
·
vor 35 Min.
Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn
MT Newswires
·
vor 1 Std.
Merck's Keytruda Meets Main Goal in Phase 3 Endometrial Cancer Trial
Business Wire
·
vor 1 Std.
Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
Business Wire
·
vor 1 Std.
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy
Trefis
·
vor 18 Std.
What Lilly's Peer-Beating Numbers Cost You
24/7 Wall St.
·
vor 20 Std.
This Healthcare Giant Still Checks Every Box for Long-Term Investors
Frag BlackSpecter AI über MRK
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist MRK kaufenswert?
MRK Earnings Analyse
MRK Bewertung
AI Chat öffnen →